Camille Abboud, MD, Oncology, Saint Louis, MO, Barnes-Jewish Hospital

CamilleNAbboudMD

Oncology Saint Louis, MO

Hematologic Oncology

Professor of Medicine Section BMT and Leukemia

Dr. Abboud is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Abboud's full profile

Already have an account?

Summary

  • Dr. Camille Abboud is an oncologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Siteman Cancer Center. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 43 years. He also speaks multiple languages, including French and Arabic. He specializes in hematologic oncology and is experienced in hematologic oncology, acute myeloid leukemia, hairy cell leukemia, lymphoma, and cellular therapy including marrow and peripheral blood stem cell transplants and CAR-T treatment of lymphoma, myeloma and Acute Lymphoblastic Leukemia.

Education & Training

  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1974

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2023
  • MO State Medical License
    MO State Medical License 2006 - 2022
  • NY State Medical License
    NY State Medical License 1975 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Single Institution Experience with G-CSF Mobilized T-cell Replete Haploidentical Hematopoietic Cell Transplantation  
    M A Schroeder, R Romee, J F DiPersio, T A Fehniger, F Gao, G L Uy, C N Abboud, P Westervelt, R Vij, Nature

Abstracts/Posters

  • Efficacy and Safety of Bosutinib By Charlson Comorbidity Index in Previously Treated Patients with Chronic Myeloid Leukemia: Results from the Phase 4 BYOND Study
    Camille Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • SEL120 _ a First-in-Class CDK8/19 Inhibitor As a Novel Option for the Treatment of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome - Data from Preclinica...
    Camille Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Maintenance of Health-Related Quality of Life in the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase Chronic Myeloid Leukemia
    Camille Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Siteman Cancer Center to Open North St. Louis County Location July 1
    Siteman Cancer Center to Open North St. Louis County Location July 1June 30th, 2017

Professional Memberships

Other Languages

  • French, Arabic

Hospital Affiliations